Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05530694 · ClinicalTrials.gov registry record · NA
Rheumatoid Arthritis Shared Decision Making
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 900
- Enrollment target
NCT05530694: Completed NA study, sponsored by VA Office of Research and Development.
NCT05530694 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 900 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05530694, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
Study Summary
Shared decision making is the first overarching principle for the treat to target guidelines for rheumatoid arthritis (RA) and has been proposed as a potential mechanism to reduce health disparities, however there is little evidence to inform effective ways to implement this practice in the care of Veterans with RA. The purpose of this project is to evaluate the effectiveness of a multi-component shared decision making intervention on RA disease activity, adherence to RA medications and patient knowledge of RA. The proposed research will contribute to fundamental knowledge about how to effectively foster shared decision making across varied VA rheumatology clinical settings to improve patient disease outcomes and experience; and support clinicians to engage patients in meaningful ways with the ultimate goal to improve health, reduce disability, and eliminate disparities.
Primary Outcome
RA disease activity will be measured using composite score: the Clinical Disease Activity Index (range 0-76) or CDAI. This is a composite score of clinician assessed swollen and tender joints counts, clinician global assessment and patient global assessment of disease activity. Higher score is indicative of higher disease activity.
Interventions
- BEHAVIORAL Patient activation
- BEHAVIORAL Clinician communication training
- BEHAVIORAL RA Medication summary guide and RA Choice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2026-02-23 |
| Phase | NA |
What the finished NCT05530694 record still lists
NCT05530694 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower).
The record links to 0 conditions, and to 3 interventions - of which Patient activation is the first listed.
NCT05530694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05530694 about?
NCT05530694 is a clinical study titled "Rheumatoid Arthritis Shared Decision Making". Shared decision making is the first overarching principle for the treat to target guidelines for rheumatoid arthritis (RA) and has been proposed as a potential mechanism to reduce health disparities, however there is little evidence to inform effective ways to implement this practice in the care of ...
What is the current status of trial NCT05530694?
This trial is currently completed. It is a NA study. The enrollment target is 900 participants. The study started on 2022-09-19. Estimated completion is 2026-02-23.
What interventions are being tested in trial NCT05530694?
The interventions under investigation include: Patient activation (BEHAVIORAL), Clinician communication training (BEHAVIORAL), RA Medication summary guide and RA Choice (BEHAVIORAL).
Who is sponsoring clinical trial NCT05530694?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05530694's enrollment target sits among peer trials
900 124th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI